Protective effects of crocin against hepatic damages in D-galactose aging model in rats
Conclusion: Gathered data prove the efficacy of gliptins in managing MeS in some levels beyond anti-diabetic effects. This review could be a lead for introducing new DPP-4 inhibitors with greatest effects on MeS in future.
Source: Iranian Journal of Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research
More News: Diabetes | Drugs & Pharmacology | Endocrinology | Iran Health | Metabolic Syndrome | Study